Plant Health Care (AIM: PHC.L), a leading provider of natural products for plants and soil, was notified on 2 June 2009 that on the same day Boulder River Capital Corporation and its affiliates had a total interest in 3,200,000 ordinary shares of 1p each in the Company ('Ordinary Shares'). This holding represents approximately 6.12% of the total issued share capital of the Company.
- ends -
For Further Information:
John Brady
Evolution Securities Limited
Tavistock Communications
Chief Executive
Tim Worlledge/Tim Redfern
Jeremy Carey/Simon Compton
Tel: 001 603 525 3702
Tel: 020 7071 4300
Tel: 020 7920 3150
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.